REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,116,054 | +5.7% | 76,447 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $2,002,827 | +22.0% | 74,872 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $1,641,460 | +9.8% | 75,783 | +20.8% | 0.00% | 0.0% |
| Q4 2022 | $1,494,275 | +43.0% | 62,732 | +18.4% | 0.00% | – |
| Q3 2022 | $1,045,000 | +21.1% | 52,999 | +19.6% | 0.00% | – |
| Q2 2022 | $863,000 | -22.9% | 44,308 | +1.0% | 0.00% | – |
| Q1 2022 | $1,119,000 | +3.2% | 43,859 | +1.8% | 0.00% | – |
| Q4 2021 | $1,084,000 | -8.5% | 43,071 | 0.0% | 0.00% | – |
| Q3 2021 | $1,185,000 | +10.5% | 43,071 | +27.4% | 0.00% | – |
| Q2 2021 | $1,072,000 | -3.9% | 33,799 | +39.0% | 0.00% | – |
| Q1 2021 | $1,116,000 | +441.7% | 24,321 | +367.4% | 0.00% | – |
| Q4 2020 | $206,000 | 0.0% | 5,204 | -12.3% | 0.00% | – |
| Q3 2020 | $206,000 | +119.1% | 5,932 | +100.3% | 0.00% | – |
| Q2 2020 | $94,000 | -79.2% | 2,961 | -85.7% | 0.00% | – |
| Q1 2020 | $453,000 | – | 20,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |